Natco Pharma gets warning letter from USFDA for Telangana plant

The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *